Novartis, CH0012005267

Novartis stock has results on October 27 ahead of the Xetra open

Published on 10/26/2026 at 08:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The pharmaceutical group is due to report third-quarter results on October 27, 2026. At Lang & Schwarz the stock trades pre-market at EUR 135.59 on October 26, 2026.

Upcoming company reporting

  • Novartis has scheduled its third-quarter 2026 results for October 27, 2026.
  • The investor webcast is listed for 1:00 p.m. CET.
  • Novartis stock trades pre-market at EUR 135.59 at 8:00 a.m. CET at Lang & Schwarz on October 26, 2026.
Novartis, CH0012005267, Illustration mit AI erstellt.

Novartis lists its third-quarter 2026 results for October 27, 2026, according to the company’s investor calendar. Novartis stock trades pre-market at EUR 135.59 at 8:00 a.m. CET at Lang & Schwarz on October 26, 2026.

Upcoming quarterly results

The company’s investor page lists the results webcast for 1:00 p.m. CET, 12:00 p.m. GMT and 8:00 a.m. EDT on the reporting date. The event is listed in Basel, Switzerland, and is identified as third-quarter results 2026 by Novartis.

Ahead of the Xetra open

Trading remains in the pre-market phase before the Xetra session. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Novartis stock.

The group and its market

Novartis develops, manufactures and markets pharmaceutical products for global markets. The company’s next scheduled reporting event is the third-quarter results publication on October 27, 2026. Market context: Market report SMI.

More news and analysis on Novartis stock

Disclaimer...
en | CH0012005267 | NOVARTIS | boerse | 70412399 |